Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo

Journal of Neuroendocrinology

Volumn 16, Issue 1, 2004, Pages 58-63

  Ciriza, I ^a   Azcoitia, I ^b   Garcia Segura, Luis M ^a  

^a INSTITUTO CAJAL   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Dentate gyrus; Dihydroprogesterone; Neurodegeneration; Neuroprotection; Tetrahydroprogesterone

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3BETA,5ALPHA TETRAHYDROPROGESTERONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 5ALPHA PREGNANE 3,20 DIONE; DRUG METABOLITE; EXCITOTOXIN; KAINIC ACID; PROGESTERONE; STEROID; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASTROCYTE; BODY WEIGHT; BRAIN INJURY; CELL ACTIVITY; CELL COUNT; CELL DEATH; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; DENTATE GYRUS; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; HIPPOCAMPUS; IMMUNOREACTIVITY; ISOMER; LOW DRUG DOSE; METABOLITE; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OPTICS; OVARIECTOMY; PRIORITY JOURNAL; PROGESTERONE METABOLISM; PROTEIN EXPRESSION; RAT; RAT STRAIN; REVIEW; STATISTICAL SIGNIFICANCE;

ANIMALS; CELL DEATH; DENTATE GYRUS; DIHYDROTESTOSTERONE; EXCITATORY AMINO ACID AGONISTS; FEMALE; KAINIC ACID; NEURONS; NEUROPROTECTIVE AGENTS; PREGNANOLONE; PROGESTERONE; RATS; RATS, WISTAR;

EID: 0742272125     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2004.01121.x     Document Type: Review

References (67)

1. McEwen BS. How do sex and stress hormones affect nerve cells? Ann NY Acad Sci 1994; 743: 1-16.
2. Bicknell RJ. Sex-steroid actions on neurotransmission. Curr Opin Neurol 1998; 11: 667-671.
3. Chowen JA, Azcoitia I, Cardona-Gomez GP, Garcia-Segura LM. Sex steroids and the brain: lessons from animal studies. J Pediatr Endocrinol Metab 2000: 13: 1045-1066.
4. Stein DG. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? Trends Neurosci 2001; 24: 386-391.
5. Melcangi RC, Martini L, Galbiati M. Growth factors and steroid hormones: a complex interplay in the hypothalamic control of reproductive functions. Prog Neurobiol 2002; 67: 421-449.
6. Ogata T, Nakamura Y, Tsuji K, Shibata T, Kataoka K. Steroid hormones protect spinal cord neurons from glutamate toxicity. Neuroscience 1993: 55: 445-449.
7. Nilsen J, Brinton RD. Impact of progestins on estrogen-induced neuro-protection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 2002; 143: 205-212.
8. YuWH. Survival of motoneurons following axotomy is enhanced by lactation or by progesterone treatment. Brain Res 1989; 491: 379-382.
9. Gonzalez Deniselle MC, Lopez-Costa JJ, Saavedra JP, Pietranera L, Gonzalez SL, Garay L, Guennoun R. Schumacher M, De Nicola AF. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol Dis 2002; 11: 457-468.
10. Callier S, Morissette M, Grandbois M, Pelaprat D, Di Paolo T. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57B1/6 mice. Synapse 2001; 41: 131-138.
11. Roof RL, Duvdevani R. Stein DG. Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res 1993; 607: 333-336.
12. Roof RL, Duvdevani R. Braswell L, Stein DG. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol 1994; 129: 64-69.
13. Roof RL, Hoffman SW. Stein DG. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol 1997: 31: 1-11.
14. Roof RL, Hall ED. Gender differences in acute CNS trauma and stroke. neuroprotective effects of estrogen and progesterone. J Neurotrauma 2000; 17: 367-388.
15. Stein DG, Hoffman SW. Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr Rehabil 2003; 6: 13-22.
16. Murphy SJ, Littleton-Kearney MT, Hurn PD. Progesterone administration during reperfusion, but not preischemia alone, reduces injury in ovariectomized rats. J Cereb Blood Flow Metab 2002; 22: 1181-1188.
17. Labombarda F, Gonzalez SL, Gonzalez DM, Guennoun R, Schumacher M, De Nicola AF. Cellular basis for progesterone neuroprotection in the injured spinal cord. J Neurotrauma 2002; 19: 343-355.
18. Cervantes M, Gonzalez-Vidal MD, Ruelas R, Escobar A, Morali G. Neuroprotective effects of progesterone on damage elicited by acute global cerebral ischemia in neurons of the caudate nucleus. Arch Med Res 2002; 33: 6-14.
19. Kumon Y, Kim SC, Tompkins P, Stevens A, Sakaki S, Loftus CM. Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia. J Neurosurg 2000; 92: 848-852.
20. Chen J, Chopp M, Li Y. Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat. J Neurol Sci 1999; 171: 24-30.
21. Thomas AJ, Nockels RP, Pan HQ, Shaffrey CI, Chopp M. Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine 1999; 24: 2134-2138.
22. Shear DA, Galani R, Hoffman SW, Stein DG. Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury. Exp Neurol 2002; 178: 59-67.
23. Asbury ET, Fritts ME, Horton JE, Isaac WL. Progesterone facilitates the acquisition of avoidance learning and protects against subcortical neuronal death following prefrontal cortex ablation in the rat. Behav Brain Res 1998; 97: 99-106.
24. Hoffman GE, Moore N, Fiskum G, Murphy AZ. Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp Neurol 2003; 182: 124-134.
25. Herzog AG, Frye CA. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol 2003; 53: 390-391.
26. Herzog AG. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 1999; 52: 1917-1918.
27. Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 1976; 54: 321-347.
28. Frye CA, Bayou LE. Cyclic withdrawal from endogenous and exogenous progesterone increases kainic acid and perforant pathway induced seizures. Pharmacol Biochem Behav 1999; 62: 315-321.
29. Edwards HE, Epps T, Carlen PL, MacLusky J. Progestin receptors mediate progesterone suppression of epileptiform activity in tetanized hippocampal slices in vitro. Neuroscience 2000; 101: 895-906.
30. Stoffel-Wagner B, Watzka M, Steckelbroeck S, Wickert L, Schramm J, Romalo G, Klingmuller D, Schweikert HU. Expression of 5alpha-reductase in the human temporal lobe of children and adults. J Clin Endocrinol Metab 1998; 83: 3636-3642.
31. Mellon SH, Griffin LD. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab 2002: 13: 35-43.
32. Frye CA, Manjarrez J, Camacho-Arroyo I. Infusion of 3alpha,5alpha-THP to the pontine reticular formation attenuates PTZ-induced seizures. Brain Res 2000; 881: 98-102.
33. Compagnone NA, Mellon SH. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol 2000; 21: 1-56.
34. Frye CA. The neurosteroid 3 alpha, 5 apha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res 1995; 696: 113-120.
35. Frye CA, Scalise TJ. Anti-seizure effects of progesterone and 3alpha,5alpha-THP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology 2000; 25: 407-420.
36. Belelli D, Bolger MB, Gee KW. Anticonvulsant profile of the progesterone metabolite 5 alpha-pregnan-3 alpha-ol-20-one. Eur J Pharmacol 1989; 166: 325-329.
37. Taubol E, Lindstrom S. The effect of progesterone and its metabolite 5 alpha-pregnan-3 alpha-ol-20-one on focal epileptic seizures in the cat's visual cortex in vivo. Epilepsy Res 1993; 14: 17-30.
38. Luntz-Leybman V, Freund RK, Collins AC. 5 alpha-Pregnan-3 alpha-ol-20-one blocks nicotine-induced seizures and enhances paired-pulse inhibition. Eur J Pharmacol 1990; 185: 239-242.
39. Reddy DS, Rogawski MA. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia 2001; 42: 337-344.
40. Smith SS. Withdrawal properties of a neuroactive steroid: implications for GABA(A) receptor gene regulation in the brain and anxiety behavior. Steroids 2002; 67: 519-528.
41. Kokate TG, Banks MK, Magee T, Yamaguchi S, Rogawski MA. Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J Pharmacol Exp Ther 1999; 288: 679-684.
42. Brot MD, Akwa Y, Purdy RH, Koob GF, Britton KT. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. Eur J Pharmacol 1997; 325: 1-7.
43. Bitran D, Purdy RH, Kellogg CK. Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function. Pharmacol Biochem Behav 1993; 45: 423-428.
44. Guidotti A, Dong E, Matsumoto K, Pinna G, Rasmusson AM, Costa E. The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5alpha-dihydroprogesterone in psychiatric disorders. Brain Res Rev 2001; 37: 110-115.
45. Frank C, Sagratella S. Neuroprotective effects of allopregnenolone on hippocampal irreversible neurotoxicity in vitro. Prog Neuropsychopharmacol Biol Psychiatry 2000; 24: 1117-1126.
46. Lockhart EM, Warner DS, Pearlstein RD, Penning DH, Mehrabani S, Boustany RM. Allopregnanolone attenuates N-methyl-D-aspartate-induced excitotoxicity and apoptosis in the human NT2 cell line in culture. Neurosci Lett 2002; 328: 33-36.
47. Leskiewicz M, Budziszewska B, Jaworska-Feil L, Lason W. Effects of neurosteroids on kainate-induced seizures, neurotoxicity and lethality in mice. Pol J Pharmacol 1997; 49: 411-417.
48. Buckmaster PS, Dudek FE. Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainate-treated rats. J Comp Neurol 1997; 385: 385-404.
49. Howard CV, Reed MG. Unbiased stereology. Three-Dimensional Measurement in Microscopy. Oxford: BIOS Scientific Publishers, 1998.
50. Hatton WJ, von Bartheld CS. Analysis of cell death in the trochlear nucleus of the chick embryo: calibration of the optical disector counting method reveals systematic bias. J Comp Neurol 1999; 409: 169-186.
51. Paxinos G, Watson C. The Rat Brain in Sterotaxic Coordinates. Sydney: Academic Press, 1986.
52. Eddleston M, Mucke L. Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience 1993; 54: 15-36.
53. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 1997; 20: 570-577.
54. Celotti F, Melcangi RC, Martini L. The 5 alpha-reductase in the brain: molecular aspects and relation to brain function. Front Neuroendocrinol 1992; 13: 163-215.
55. Melcangi RC, Magnaghi V, Martini L. Steroid metabolism and effects in central and peripheral glial cells. J Neurobiol 1999; 40: 471-483.
56. Soltesz I, Mody I. Patch-clamp recordings reveal powerful GABAergic inhibition in dentate hilar neurons. J Neurosci 1994; 14: 2365-2376.
57. Lambert JJ, Belelli D, Hill-Venning C, Peters JA. Neurosteroids and GABAA receptor function. Trends Pharmacol Sci 1995; 16: 295-303.
58. Magnaghi V, Cavarretta I, Galbiati M, Martini L, Melcangi RC. Neuroactive steroids and peripheral myelin proteins. Brain Res Rev 2001; 37: 360-371.
59. Alves SE, McEwen BS, Hayashi S, Korach KS, Pfaff DW, Ogawa S. Estrogen-regulated progestin receptors are found in the midbrain raphe but not hippocampus of estrogen receptor alpha (ER alpha) gene-disrupted mice. J Comp Neurol 2000; 427: 185-195.
60. MacLusky NJ, Chalmers-Redman R, Kay G, Ju W, Nethrapalli IS, Tatton WG. Ovarian steroids reduce apoptosis induced by trophic insufficiency in nerve growth factor-differentiated PC12 cells and axotomized rat facial motoneurons. Neuroscience 2003; 118: 741-754.
61. Akwa Y, Sananes N, Gouezou M, Robel P, Baulieu EE, Le Goascogne C. Astrocytes and neurosteroids: metabolism of pregnenolone and dehydroepiandrosterone. Regulation by cell density. J Cell Biol 1993; 121: 135-143.
62. Jung-Testas I, Hu ZY, Baulieu EE, Robel P. Neurosteroids: biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. Endocrinology 1989; 125: 2083-2091.
63. Mellon SH, Griffin LD. Synthesis, regulation, and function of neurosteroids. Endocr Res 2002; 28: 463.
64. di Michele F, Lekieffre D, Pasini A, Bernardi G, Benavides J, Romeo E. Increased neurosteroids synthesis after brain and spinal cord injury in rats. Neurosci Lett 2000; 284: 65-68.
65. Azcoitia I, Fernandez-Galaz C, Sierra A, Garcia-Segura LM. Gonadal hormones affect neuronal vulnerability to excitotoxin-induced degeneration. J Neurocytol 1999; 28: 699-710.
66. Velisek L, Veliskova J, Etgen AM, Stanton PK, Moshe SL. Region-specific modulation of limbic seizure susceptibility by ovarian steroids. Brain Res 1999; 842: 132-138.
67. Murphy SJ, Traystman RJ, Hurn PD, Duckles SP. Progesterone exacerbates striatal stroke injury in progesterone-deficient female animals. Stroke 2000; 31: 1173-1178.